Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

Aspirin (niedrig dosiert) – Forschungsarchiv – Seite 34 von 60 | SupStack

Aspirin (niedrig dosiert) – Forschungsarchiv

Studien 2601–2650 von 3915, neueste zuerst

Die 1000 neuesten Studien – mit Evidenz-Zusammenfassung, Filtern und Suche – stehen auf der Hauptseite. Dieses Archiv listet die übrigen, 50 pro Seite. Zurück zur Hauptseite

2601RCT2000

Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS, McDougall J · Am J Obstet Gynecol (2000)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

Aspirin (niedrig dosiert) – Forschungsarchiv

Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS).

Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment.

Negative interaction of aspirin and streptokinase in acute ischemic stroke: further analysis of the Multicenter Acute Stroke Trial-Italy.

Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses.

Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial.

[Clinical effectiveness and specific action of antiaggregants in patients with unstable angina].

[Aspirin vs ticlid and their combination in patients with acute myocardial infarction].

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators.

Randomized comparative trial of triflusal and aspirin following acute myocardial infarction.

Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: do the results apply to all patients?

[Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].

Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans.

Antiplatelet is superior to anticoagulant treatment after coronary stenting: fewer coronary and other events within 30 days after stenting.

Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage.

Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.

[Acetylsalicylic acid effects on pain sensitivity to myocardial ischemia and skin sensitivity in patients with angina pectoris].

Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis.

Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.

Is aspirin all it is cracked up to be-reproducibility of transvaginal color Doppler ultrasonography for ovarian and uterine vessels?

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.

Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.

A safe and effective regimen without heparin therapy after successful primary coronary stenting in patients with acute myocardial infarction.

Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty.

Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.

Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group.

Baseline characteristics of participants in the Women's Health Study.

Effects of warfarin, aspirin and the two combined, on mortality and thromboembolic morbidity after myocardial infarction. The WARIS-II (Warfarin-Aspirin Reinfarction Study) design.

Piracetam versus acetylsalicylic acid in secondary stroke prophylaxis. A double-blind, randomized, parallel group, 2 year follow-up study.

Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris.

Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin.

Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials.

ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy.

Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.

Effect of short-term aspirin use on C-reactive protein.

The effectiveness of combined oral lysine acetylsalicylate and metoclopramide (Migpriv) in the treatment of migraine attacks. Comparison with placebo and oral sumatriptan.

Acetylsalicylic acid does not reduce the intraocular pressure variation in ocular hypertension or glaucoma.

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents.

Acetylsalicylic acid and autonomic modulation.

A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks.

Antiplatelet agents for preventing and treating pre-eclampsia.

Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial.

Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes.

40 mg of aspirin are not sufficient to inhibit platelet function under conditions of limited compliance.

Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.

Interaction between the LMWH reviparin and aspirin in healthy volunteers.

Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.

Aspirin for vascular dementia.

Single dose oral aspirin for acute pain.

Antihistamines versus aspirin for itching in late pregnancy.